Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

pWRG/HTN-M(co)/pWRG/PUUV-M(s2)

Next Previous
Drug Profile

pWRG/HTN-M(co)/pWRG/PUUV-M(s2)

Alternative Names: Hantaan virus/puumala virus DNA vaccine; Hantaan/puumala virus DNA vaccine; Hantaan/puumala virus vaccine; HTNV/PUU DNA vaccine; HTNV/PUUV DNA vaccine; Puumala/hantaan virus DNA vaccine; pWRG/HTN-M(co)/pWRG/PUU-M(s2); pWRG/HTN-M(x)/pWRG/PUU-M(s2); pWRG/HTN-M(x)/pWRG/PUUV-M(s2)

Latest Information Update: 31 Oct 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ichor Medical Systems; United States Army Medical Research and Materiel Command
  • Class DNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Viral haemorrhagic fevers

Most Recent Events

  • 31 Oct 2018 U.S. Army Medical Research and Materiel Command plans a phase I trial for Viral haemorrhagic fevers (Prevention; caused by hantaan and puumala virus) in May 2019 (NCT03718130)
  • 26 Dec 2016 Phase-II development is ongoing in USA (NCT02116205)
  • 01 Aug 2016 United States Army Medical Research and Materiel Command initiates a phase I trial in Viral haemorrhagic fevers (Prevention) in USA (IM) (NCT02776761)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top